全文获取类型
收费全文 | 36748篇 |
免费 | 3831篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 215篇 |
儿科学 | 1202篇 |
妇产科学 | 986篇 |
基础医学 | 5185篇 |
口腔科学 | 751篇 |
临床医学 | 4379篇 |
内科学 | 6722篇 |
皮肤病学 | 558篇 |
神经病学 | 3187篇 |
特种医学 | 1450篇 |
外国民族医学 | 3篇 |
外科学 | 4769篇 |
综合类 | 825篇 |
一般理论 | 44篇 |
预防医学 | 4437篇 |
眼科学 | 893篇 |
药学 | 2824篇 |
中国医学 | 46篇 |
肿瘤学 | 2130篇 |
出版年
2022年 | 282篇 |
2021年 | 640篇 |
2020年 | 336篇 |
2019年 | 606篇 |
2018年 | 634篇 |
2017年 | 489篇 |
2016年 | 543篇 |
2015年 | 571篇 |
2014年 | 806篇 |
2013年 | 1199篇 |
2012年 | 1734篇 |
2011年 | 1708篇 |
2010年 | 984篇 |
2009年 | 893篇 |
2008年 | 1544篇 |
2007年 | 1632篇 |
2006年 | 1623篇 |
2005年 | 1557篇 |
2004年 | 1504篇 |
2003年 | 1425篇 |
2002年 | 1348篇 |
2001年 | 1269篇 |
2000年 | 1288篇 |
1999年 | 1102篇 |
1998年 | 437篇 |
1997年 | 395篇 |
1996年 | 363篇 |
1995年 | 324篇 |
1994年 | 352篇 |
1993年 | 338篇 |
1992年 | 877篇 |
1991年 | 821篇 |
1990年 | 814篇 |
1989年 | 733篇 |
1988年 | 742篇 |
1987年 | 692篇 |
1986年 | 636篇 |
1985年 | 690篇 |
1984年 | 562篇 |
1983年 | 437篇 |
1982年 | 286篇 |
1981年 | 296篇 |
1980年 | 270篇 |
1979年 | 479篇 |
1978年 | 362篇 |
1977年 | 279篇 |
1976年 | 286篇 |
1974年 | 319篇 |
1973年 | 293篇 |
1972年 | 294篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
111.
Florian A Kagerer Jeff J Summers Winston D Byblow Bruce Taylor 《Movement disorders》2003,18(8):919-927
In 6 patients with Parkinson's disease (PD) and 6 age-matched controls, transcranial magnetic stimulation was applied at 56 regions over the motor cortex and premotor cortex of each hemisphere, with the first dorsal interosseous (FDI) muscle of both hands activated at 15% maximum voluntary contraction during stimulation. For each site, motor evoked potential (MEP) landmarks were recovered, including MEP amplitude, MEP onset latency, and silent period duration. Scaled MEP amplitudes were used to construct individual cortical maps of the FDI muscles. The maps revealed an anterior displacement of the muscle representation in PD patients. This anterior shift over motor cortical areas may reflect increased contributions of corticocortical connections between motor cortex and premotor cortical areas, possibly enhanced by the visual feedback aspect of the task. These alterations may reflect adaptations to the impairments in striatocortical circuits in PD. 相似文献
112.
113.
Michele L Ries Britta M Jabbar Taylor W Schmitz Mehul A Trivedi Carey E Gleason Cynthia M Carlsson Howard A Rowley Sanjay Asthana Sterling C Johnson 《Journal of the International Neuropsychological Society》2007,13(3):450-461
Awareness of cognitive dysfunction shown by individuals with Mild Cognitive Impairment (MCI), a condition conferring risk for Alzheimer's disease (AD), is variable. Anosognosia, or unawareness of loss of function, is beginning to be recognized as an important clinical symptom of MCI. However, little is known about the brain substrates underlying this symptom. We hypothesized that MCI participants' activation of cortical midline structures (CMS) during self-appraisal would covary with level of insight into cognitive difficulties (indexed by a discrepancy score between patient and informant ratings of cognitive decline in each MCI participant). To address this hypothesis, we first compared 16 MCI participants and 16 age-matched controls, examining brain regions showing conjoint or differential BOLD response during self-appraisal. Second, we used regression to investigate the relationship between awareness of deficit in MCI and BOLD activity during self-appraisal, controlling for extent of memory impairment. Between-group comparisons indicated that MCI participants show subtly attenuated CMS activity during self-appraisal. Regression analysis revealed a highly significant relationship between BOLD response during self-appraisal and self-awareness of deficit in MCI. This finding highlights the level of anosognosia in MCI as an important predictor of response to self-appraisal in cortical midline structures, brain regions vulnerable to changes in early AD. 相似文献
114.
115.
The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report--2004. 总被引:17,自引:0,他引:17
116.
117.
118.
A J Taylor 《The New Zealand medical journal》1989,102(878):562-563
119.
Seventy patients with abnormal vaginal bleeding were examined with a Storz hysteroscope. The examination took an average of only 5 min. Sixty patients had the examination under general anaesthesia, five under paracervical block and five had no form of anaesthesia. All tolerated the procedure well. There were no complications directly related to the hysteroscopic examination. There was complete correlation between the histology of the endometrium obtained at subsequent curettage and the hysteroscopic findings. 相似文献
120.
Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin 总被引:7,自引:0,他引:7
M Manning M Kruszynski K Bankowski A Olma B Lammek L L Cheng W A Klis J Seto J Haldar W H Sawyer 《Journal of medicinal chemistry》1989,32(2):382-391
We describe the synthesis and some pharmacological properties of 16 new in vivo antagonists of oxytocin. These are based on modifications of three peptides: A, B, and C. A is our previously reported potent and selective antagonist of the vasopressor (V1 receptor) responses to arginine-vasopressin (AVP)/weak oxytocin antagonist, [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid), 2-O-methyltyrosine]arginine-vasopressin (d(CH2)5[Tyr(Me)2]AVP. B reported here, the Ile3 analogue of A, is d(CH2)5[Tyr(Me)2]AVT (5 below) and C is our previously reported potent nonselective oxytocin antagonist/AVP V1 antagonist, [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-O- methyltyrosine,8-ornithine]vasotocin (d(CH2)5[Tyr(Me)2]OVT). The following substitutions and deletions, alone or in combination, were employed in A, B, and C: 1-deaminopenicillamine (dP); D-Tyr(Alk)2 (where Alk = Me or Et), D-Phe2; Val4, Thr4; delta 3-Pro7; Lys8, Cit8; desGly9, desGly-NH2(9), Ala-NH2(9); Leu-NH2(9); Arg-NH2(9). The 16 new analogues are (1) d(CH2)5[D-Tyr(Me)2]AVP, (2) d(CH2)5[D-Tyr(Me)2, Val4,delta 3-Pro7]AVP, (3) d(CH2)5[D-Tyr-(Et)2, Val4,Lys8]VP, (4) d(CH2)5[D-Tyr(Et)2,Val4,Cit8]VP, (5) d(CH2)5[Tyr(Me)2]AVT, (6) d(CH2)5[Tyr(Me)2,Lys8]VT, (7) dP[Tyr(Me)2]AVT, (8) dP[Tyr(Me)2,Val4]AVT, (9) d(CH2)5[D-Tyr(Me)2, Val4]AVT, (10) d(CH2)5[D-Phe2,Val4]AVT, (11) d(CH2)5[Tyr(Me)2,Thr4]OVT, (12) d(CH2)5[Tyr(Me)2,Thr4,Ala-NH2(9)]OVT, (13) d(CH2)5[Tyr(Me)2,Thr4,Leu-NH2(9)]OVT, (14) d(CH2)5[Tyr(Me)2,Thr4,Arg-NH2(9)]OVT, (15) desGly-NH2(9),d(CH2)5[Tyr(Me)2,Thr4]OVT, (16) desGly9,d(CH2)5[Tyr(Me)2,Thr4]OVT. 1-4 are analogues of A, 5-10 are analogues of B, and 11-16 are analogues of C. Their protected precursors were synthesized either entirely by the solid-phase method or by a combination of solid-phase and solution methods (1 + 8 or 8 + 1 couplings). All analogues were tested in rats for agonistic and antagonistic activities in oxytocic (in vitro, without and with Mg2+, and in vivo) assays as well as by antidiuretic and vasopressor assays. All analogues exhibit potent oxytocic antagonism in vitro and in vivo. With an in vitro pA2 (in the absence of Mg2+) = 9.12 +/- 0.09, dP[Tyr(Me)2]AVT is (7) one of the most potent in vitro oxytocin antagonists reported to date. Fifteen of these analogues (all but 6) appear as potent or more potent in vivo oxytocin antagonists than C (pA2 = 7.37 +/- 0.17). Analogues 1-9 and 14 are potent AVP V1 antagonists. Their anti-V1 pA2 values range from 7.92 to 8.45. They are thus nonselective oxytocin antagonists.(ABSTRACT TRUNCATED AT 400 WORDS) 相似文献